Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 USD | +0.48% |
|
+7.73% | -8.73% |
06-24 | Checkpoint Therapeutics Plans to Resubmit Application for Cancer Treatment Candidate | MT |
06-24 | Checkpoint Therapeutics Reaches BLA Alignment With FDA for Cosibelimab | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.73% | 77.02M | |
+38.36% | 52.73B | |
+38.62% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- CKPT Stock
- News Checkpoint Therapeutics, Inc.
- Checkpoint Therapeutics Receives Pediatric Investigational Plan Waivers for Skin Cancer Drug Candidate